Michael A Metzger, Director, Chief Executive Officer, on July 08, 2026, sold 32,375 shares in Syndax Pharmaceuticals (SNDX) for $784,776. Following the Form 4 filing with the SEC, Metzger has control over a total of 484,843 common shares of the company, with 484,843 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1395937/000119312526299803/xslF345X05/ownership.xml
James E Mangold, Vice President, Lending, on June 29, 2026, executed a purchase for 39,950 shares in EWSB Bancorp (EWSB) for $399,500. Following the Form 4 filing with the SEC, Mangold has control over a total of 98,068 common shares of the company, with 8,302 shares held directly and 89,766 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2013792/000143774926023066/xslF345X05/rdgdoc.xml
Gary G Friedman, 10% Owner, Director, Chairman, and CEO, on July 06, 2026, sold 125,000 shares in RH (RH) for $20,668,231. Following the Form 4 filing with the SEC, Friedman has control over a total of 3,226,337 common shares of the company, with 3,226,337 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1528849/000113744326000002/xslF345X05/form4-07082026_090739.xml
Robert Joseph Deshaies, COO, Benefits, on July 06, 2026, sold 2,000 shares in Wex (WEX) for $296,796. Following the Form 4 filing with the SEC, Deshaies has control over a total of 20,288 common shares of the company, with 20,288 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1309108/000178832926000015/xslF345X05/wk-form4_1783545815.xml